Ultra-small iron-based nanoparticles Mitigate rheumatoid arthritis inflammation via macrophage Repolarization and SLC7A11/GPX4-mediated ferroptosis inhibition
Source abstract
Abstract
The characteristic pathological manifestations of rheumatoid arthritis (RA) include inflammatory cell infiltration, abnormal synoviocyte proliferation, and progressive bone and cartilage destruction. An excessive buildup of reactive oxygen species (ROS) within the joints is a critical factor promoting RA pathological progression. In this study, we innovatively employed a hard template-restricted controlled sintering carbonization strategy to fabricate ultra-small Fe 3 O 4 @C nanoparticles with hierarchical structures. The ultra-small Fe 3 O 4 @C nanoparticles exhibit multiple natural enzyme-mimic catalytic activity, effectively diminishing intracellular ROS levels in macrophages, while also facilitating the polarization toward the M2 phenotype, and significantly suppresses the production of pro-inflammatory cytokines. Mechanistic investigations reveal that Fe 3 O 4 @C significantly suppresses ferroptosis in synoviocytes and chondrocytes through regulation of the SLC7A11/GPX4 signalling pathway, thereby alleviating synovial tissue erosion and promoting type II collagen synthesis. In the collagen-induced arthritis mouse model, Fe 3 O 4 @C exhibited remarkable anti-inflammatory and chondroprotective effects, providing an innovative nanozyme therapeutic approach for RA treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Ferroptosis and cancer prognosis · Immune cells in cancer · Inflammasome and immune disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. Different gender of oxidative balance score on the risk of rheumatoid arthritis in the US population from NHANES10.1111/1756-185X.15237 ↗
2. A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization10.1016/j.redox.2024.103059 ↗
3. Blocking TRPV4 ameliorates osteoarthritis by inhibiting M1 macrophage polarization via the ROS/NLRP3 signaling pathway10.3390/antiox11122315 ↗
4. Effects of folate-chicory acid liposome on macrophage polarization and TLR4/NF-κB signaling pathway in ulcerative colitis mouse10.1016/j.phymed.2024.155415 ↗
5. The role of reactive oxygen species in the rheumatoid arthritis-associated synovial microenvironment10.3390/antiox11061153 ↗
6. Natural products in rheumatoid arthritis: cell type-specific mechanisms and therapeutic implications10.1016/j.phymed.2025.156980 ↗
7. Rheumatoid arthritis: advances in treatment strategies10.1007/s11010-022-04492-3 ↗
8. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles10.1038/nnano.2007.260 ↗
9. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes10.1039/c3cs35486e ↗
10. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)10.1039/C8CS00457A ↗
11. Nanozyme: new horizons for responsive biomedical applications10.1039/C8CS00718G ↗
12. Nanozymes: classification, catalytic mechanisms, activity regulation, and applications10.1021/acs.chemrev.8b00672 ↗
13. Nanozymes: from new concepts, mechanisms, and standards to applications10.1021/acs.accounts.9b00140 ↗
14. Structure and activity of nanozymes: inspirations for de novo design of nanozymes10.1016/j.mattod.2020.08.020 ↗
15. Metal‐based nanozymes with multienzyme‐like activities as therapeutic candidates: applications, mechanisms, and optimization strategy10.1002/smll.202205870 ↗
16. Multienzyme‐like nanozymes: regulation, rational design, and application10.1002/adma.202211210 ↗
17. A review on Metal- and metal oxide-based nanozymes: properties, mechanisms, and applications10.1007/s40820-021-00674-8 ↗
18. Regulating peroxidase-mimic activity of iron oxide nanozymes through size modulation: electronic structure and specific surface area10.1007/s12598-025-03349-0 ↗
19. Nanozymes: definition, activity, and mechanisms10.1002/adma.202211041 ↗
20. Depletable peroxidase-like activity of Fe(3)O(4) nanozymes accompanied with separate migration of electrons and iron ions10.1038/s41467-022-33098-y ↗
21. A bioinspired sulfur-fe-heme nanozyme with selective peroxidase-like activity for enhanced tumor chemotherapy10.1038/s41467-024-54868-w ↗
22. Ultrasmall iron oxide nanoparticles: synthesis, surface modification, assembly, and biomedical applications10.1016/j.drudis.2019.01.001 ↗
23. Size effects of electrocatalysts: more than a variation of surface area10.1021/acsnano.2c04603 ↗
24. Carbon-based nanozymes: design, catalytic mechanism, and bioapplication10.1016/j.ccr.2022.214896 ↗
25. Sun · 2023
26. Carbon-based nanozymes for biomedical applications10.1007/s12274-020-3053-9 ↗
27. Deciphering the catalytic mechanism of superoxide dismutase activity of carbon dot nanozyme10.1038/s41467-023-35828-2 ↗
28. Biodegradable janus sonozyme with continuous reactive oxygen species regulation for treating infected critical-sized bone defects10.1038/s41467-024-54894-8 ↗
29. Reactive oxygen species and neurodegenerative diseases: insights into nanozyme therapeutics
30. Facile and controllable synthesis of the renal-clearable "Luminous Pearls" for in vivo afterglow/magnetic resonance imaging10.1021/acsnano.1c07243 ↗
31. Ultra-small iron-based nanoparticles with mild photothermal-enhanced Cascade enzyme-mimic reactions for tumor therapy10.3390/ma18071649 ↗
32. Effect of Fe oxidation state (+2 versus +3) in precursor on the structure of Fe oxides/carbonates-based composites examined by XPS, FTIR and EXAFS
33. Analysis of XPS spectra of Fe2+ and Fe3+ ions in oxide materials10.1016/j.apsusc.2007.09.063 ↗
34. Nanozyme catalytic turnover and self-limited reactions10.1021/acsnano.1c07520 ↗
35. Fe(2+)/Fe(3+) cycling for coupling self-powered hydrogen evolution and preparation of electrode catalysts10.1002/anie.202207226 ↗
36. Enhancing tumor catalytic therapy by Co-Catalysis10.1002/anie.202200480 ↗
37. Tuning oxidant and antioxidant activities of ceria by anchoring copper single-site for antibacterial application10.1038/s41467-024-45255-6 ↗
38. An artificial protein modulator reprogramming neuronal protein functions10.1038/s41467-024-46308-6 ↗
39. Structure and defect engineering synergistically boost high solar-to-chemical conversion efficiency of cerium oxide/Au hollow nanomushrooms for nitrogen photofixation10.1002/anie.202316384 ↗
40. Targeted delivery of active sites by oxygen vacancy-engineered bimetal silicate nanozymes for intratumoral aggregation-potentiated catalytic therapy10.1021/acsnano.3c08780 ↗
41. Valence-engineered catalysis-selectivity regulation of molybdenum oxide nanozyme for acute kidney injury therapy and post-cure assessment10.1038/s41467-024-53047-1 ↗
42. Improved pyrogallol autoxidation method: a reliable and cheap superoxide-scavenging assay suitable for all antioxidants10.1021/jf204970r ↗
43. A natural biogenic nanozyme for scavenging superoxide radicals10.1038/s41467-023-44463-w ↗
44. Regulating peroxidase-mimic activity of iron oxide nanozymes through size modulation: electronic structure and specific surface area %J rare metals
45. Research progress in iron-based nanozymes: catalytic mechanisms, classification, and biomedical applications10.1021/acs.analchem.3c01005 ↗
46. In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy10.1038/s41467-018-03903-8 ↗
47. Arthritic microenvironment actuated nanomotors for active rheumatoid arthritis therapy10.1002/advs.202204881 ↗
48. Contribution of synovial mesenchymal cells to the pathogenesis of rheumatoid arthritis10.1016/0049-0172(92)90058-L ↗
49. Mesenchymal stem cells‐involved strategies for rheumatoid arthritis therapy10.1002/advs.202305116 ↗
50. Where to stand with stromal cells and chronic synovitis in rheumatoid arthritis?10.3390/cells8101257 ↗
51. Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs10.3389/fimmu.2023.1107670 ↗
52. Senolytic therapeutics: an emerging treatment modality for osteoarthritis10.1016/j.arr.2024.102275 ↗
53. Macrophage polarization in rheumatoid arthritis: signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts10.3389/fimmu.2024.1394108 ↗
54. Macrophage polarization and reprogramming in acute inflammation: a redox perspective10.3390/antiox11071394 ↗
55. Inhibiting acid-sensing ion channel exerts neuroprotective effects in experimental epilepsy via suppressing ferroptosis10.1111/cns.14596 ↗
56. Moxibustion’s impact on ferroptosis regulation: a key to relieving inflammatory injury in rheumatoid arthritis10.1089/rej.2024.0110 ↗
57. Paeoniflorin mitigates iron overload-induced osteoarthritis by suppressing chondrocyte ferroptosis via the p53/SLC7A11/GPX4 pathway10.1016/j.intimp.2025.115111 ↗
58. Sex hormone signaling and regulation of immune function10.1016/j.immuni.2023.10.008 ↗
59. Pharmacokinetic study of ultrasmall superparamagnetic iron oxide nanoparticles HY-088 in rats10.1007/s13318-024-00884-6 ↗
60. Photogenerated electrons from CeO2 via upconversion of excitons to conduction band enhanced photocatalysis for photo-therapy of rheumatoid arthritis
61. Engineering M2 macrophage-derived exosomes modulate activated T cell cuproptosis to promote immune tolerance in rheumatoid arthritis10.1016/j.biomaterials.2024.122943 ↗